METAOD003: A Phase IIa (double-blind, placebo-controlled 4 4 Latin Square design) safety study with single doses (9, 27 and 54 mg AOD9604) administered orally (capsules) to 17 healthy, clinically obese males presenting with a BMI 35 kg/m 2
Yang W, Chen L, Ji Q, Liu X, Ma J, Tandon N, Bhattacharyya A, Kumar A, Kim KW, Yoon KH, et al: Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial(*)
The structures were determined using single-particle cryo-electron microscopy (cryo-EM), an advanced in vitro structural biology technique that allows visualization of protein complexes at near-atomic resolution
The sex distribution is equal